Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag

被引:26
作者
Sova, P [1 ]
Volsky, DJ [1 ]
Wing, L [1 ]
Chao, W [1 ]
机构
[1] Columbia Univ, St Lukes Roosevelt Hosp Ctr, Mol Virol Lab, New York, NY 10019 USA
关键词
D O I
10.1128/JVI.75.12.5504-5517.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Vif is a human immunodeficiency virus type I (HIV-1) protein that is essential for the production of infectious virus. Most of Vif synthesized during HIV infection localizes within cells, and the extent of Vif packaging into virions and its function there remain controversial. Here we show that a small but detectable amount of Vif remains associated with purified virions even after their treatment with the protease subtilisin, However, treatment of these virions with 1% Triton X-100 revealed that most of the virion-associated Vif segregated with detergent-resistant virus particles consisting of unprocessed Gag, indicating that detergent-soluble, mature virions contain very little Vif, To investigate the control of Vif packaging in immature virus particles, we tested its association with Gag-containing virus-like particles (VLPs) in a Vif and Gag coexpression system in human cells. Only a small proportion of Vif molecules synthesized in this system became packaged into VLPs, and the VLP-associated Vif was protected from exogenous protease and detergent treatment, indicating that it is stably incorporated into immature virion-like cores. About 10-fold more Vpr than Vif was packaged into VLPs but most of the VLP-associated Vpr was removed by treatment with detergent. Mutagenesis of the C-terminal sequences in Gag previously shown to be responsible for interaction with Vif did not reduce the extent of Vif packaging into Gag VLPs, Surprisingly, short deletions in the capsid domain (CA) of Gag (amino acid residues 284 to 304 and 350 to 362) increased Vif packaging over 10-fold. The 350 to 363 deletion introduced into CA in HIV provirus also increased Vif incorporation into purified virions. Our results show that Vif can be packaged at low levels into aberrant virus particles or immature virions and that Vif is not present significantly in mature virions. Overall, these results indicate that the Vif content in virions is tightly regulated and also argue against a function of virion-associated Vif.
引用
收藏
页码:5504 / 5517
页数:14
相关论文
共 72 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   Human immunodeficiency virus type 1 Vif-derived peptides inhibit the viral protease and arrest virus production [J].
Baraz, L ;
Friedler, A ;
Blumenzweig, I ;
Nussinuv, O ;
Chen, N ;
Steinitz, M ;
Gilon, C ;
Kotler, M .
FEBS LETTERS, 1998, 441 (03) :419-426
[3]   TRANSCOMPLEMENTATION OF VIF- HIV-1 MUTANTS IN CEM CELLS SUGGESTS THAT VIF AFFECTS LATE STEPS OF THE VIRAL LIFE-CYCLE [J].
BLANC, D ;
PATIENCE, C ;
SCHULZ, TF ;
WEISS, R ;
SPIRE, B .
VIROLOGY, 1993, 193 (01) :186-192
[4]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY [J].
BORMAN, AM ;
QUILLENT, C ;
CHARNEAU, P ;
DAUGUET, C ;
CLAVEL, F .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2058-2067
[5]   Phenotypically Vif(-) human immunodeficiency virus type 1 is produced by chronically infected restrictive cells [J].
Bouyac, M ;
Rey, F ;
Nascimbeni, M ;
Courcoul, M ;
Sire, J ;
Blanc, D ;
Clavel, F ;
Vigne, R ;
Spire, B .
JOURNAL OF VIROLOGY, 1997, 71 (03) :2473-2477
[6]   Human immunodeficiency virus type 1 Vif protein binds to the Pr55(Gag) precursor [J].
Bouyac, M ;
Courcoul, M ;
Bertola, G ;
Baudat, Y ;
Gabuzda, D ;
Blanc, D ;
Chazal, N ;
Boulanger, P ;
Sire, J ;
Vigne, R ;
Spire, B .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9358-9365
[7]   UNUSUAL FEATURES OF PROTEIN-INTERACTION IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) VIRIONS [J].
BUKRINSKAYA, AG ;
SHAROVA, NK .
ARCHIVES OF VIROLOGY, 1990, 110 (3-4) :287-293
[8]   Characterization of human immunodeficiency virus type 1 Vif particle incorporation [J].
Camaur, D ;
Trono, D .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6106-6111
[9]   MACROPHAGE-TROPIC HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATES FROM DIFFERENT PATIENTS EXHIBIT UNUSUAL V3 ENVELOPE SEQUENCE HOMOGENEITY IN COMPARISON WITH T-CELL-TROPIC ISOLATES - DEFINITION OF CRITICAL AMINO-ACIDS INVOLVED IN CELL TROPISM [J].
CHESEBRO, B ;
WEHRLY, K ;
NISHIO, J ;
PERRYMAN, S .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6547-6554
[10]   vif-Negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus [J].
Chowdhury, IH ;
Chao, W ;
Potash, MJ ;
Sova, P ;
Gendelman, HE ;
Volsky, DJ .
JOURNAL OF VIROLOGY, 1996, 70 (08) :5336-5345